Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PHASE 4, STUDY OF THE EFFECT OF EARLY STEROID WITHDRAWAL IN RENAL TRANSPLANT RECEPIENTS OF A LIVING-RELATED DONOR

NCT02328222 is registered in ClinicalTrials.gov with Unidad de Investigacion Medica en Enfermedades Renales as lead sponsor.

NCT NCT02328222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02328222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PHASE 4, STUDY OF THE EFFECT OF EARLY STEROID WITHDRAWAL IN RENAL TRANSPLANT RECEPIENTS OF A LIVING-RELATED DONOR
Lead sponsor
Unidad de Investigacion Medica en Enfermedades Renales
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2010
Completion date
June 30, 2011
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease